Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Behavioral Troubles in Children with Prader-Willi Syndrome
NCT03114371Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Nov 2016
- Primary completion
- Jan 2019
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray in Prader-Willi syndrome (PWS) (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Child Behavior Checklist Global Score at 12 weeks. Started Nov 2016; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT03114371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03114371.